Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Accelerating Adolescent Vocabulary Growth: Development of an Individualized, Web-Based, Vocabulary Instruction Program.

Adlof SM, Baron LS, Scoggins J, Kapelner A, McKeown MG, Perfetti CA, Miller E, Soterwood J, Petscher Y.

Lang Speech Hear Serv Sch. 2019 Oct 10;50(4):579-595. doi: 10.1044/2019_LSHSS-VOIA-18-0143. Epub 2019 Oct 10.

PMID:
31600471
2.

Children With Dyslexia Benefit From Orthographic Facilitation During Spoken Word Learning.

Baron LS, Hogan TP, Alt M, Gray S, Cabbage KL, Green S, Cowan N.

J Speech Lang Hear Res. 2018 Aug 8;61(8):2002-2014. doi: 10.1044/2018_JSLHR-L-17-0336.

3.

Feasibility of using single-slice MDCT to evaluate visceral abdominal fat in an urban pediatric population.

Blitman NM, Baron LS, Berkenblit RG, Schoenfeld AH, Markowitz M, Freeman K.

AJR Am J Roentgenol. 2011 Aug;197(2):482-7. doi: 10.2214/AJR.10.5514.

PMID:
21785098
5.

Role of IS1 in the conversion of virulence (Vi) antigen expression in Enterobacteriaceae.

Ou JT, Huang CJ, Houng HS, Baron LS.

Mol Gen Genet. 1992 Aug;234(2):228-32.

PMID:
1324399
7.

Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.

Tacket CO, Losonsky G, Taylor DN, Baron LS, Kopecko D, Cryz S, Levine MM.

J Infect Dis. 1991 Apr;163(4):901-4.

PMID:
2010645
9.

Method for identifying microbial antigens that stimulate specific lymphocyte responses: application to Salmonella.

Warren RL, Lu D, Sizemore DR, Baron LS, Kopecko DJ.

Proc Natl Acad Sci U S A. 1990 Dec;87(24):9823-7.

12.

Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a.

Cryz SJ Jr, F├╝rer E, Baron LS, Noon KF, Rubin FA, Kopecko DJ.

Infect Immun. 1989 Dec;57(12):3863-8.

14.
16.

Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria.

Sadoff JC, Ballou WR, Baron LS, Majarian WR, Brey RN, Hockmeyer WT, Young JF, Cryz SJ, Ou J, Lowell GH, et al.

Science. 1988 Apr 15;240(4850):336-8.

PMID:
3281260
17.

Introduction of Shigella flexneri 2a type and group antigen genes into oral typhoid vaccine strain Salmonella typhi Ty21a.

Baron LS, Kopecko DJ, Formal SB, Seid R, Guerry P, Powell C.

Infect Immun. 1987 Nov;55(11):2797-801.

18.

lambda N antitermination system: functional analysis of phage interactions with the host NusA protein.

Schauer AT, Carver DL, Bigelow B, Baron LS, Friedman DI.

J Mol Biol. 1987 Apr 20;194(4):679-90.

20.

Development of a DNA probe to detect Salmonella typhi.

Rubin FA, Kopecko DJ, Noon KF, Baron LS.

J Clin Microbiol. 1985 Oct;22(4):600-5.

21.

High frequency transduction by phage hybrids between coliphage phi 80 and Salmonella phage P22.

Yamamoto N, Droffner ML, Yamamoto S, Gemski P, Baron LS.

J Gen Virol. 1985 Aug;66 ( Pt 8):1661-8.

PMID:
3894574
22.

Genetic determinants of virulence in Shigella and dysenteric strains of Escherichia coli: their involvement in the pathogenesis of dysentery.

Kopecko DJ, Baron LS, Buysse J.

Curr Top Microbiol Immunol. 1985;118:71-95. Review. No abstract available.

PMID:
2414072
23.

Expression of lipopolysaccharide O antigen in Escherichia coli K-12 hybrids containing plasmid and chromosomal genes from Shigella dysenteriae 1.

Hale TL, Guerry P, Seid RC Jr, Kapfer C, Wingfield ME, Reaves CB, Baron LS, Formal SB.

Infect Immun. 1984 Nov;46(2):470-5.

24.

Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen.

Formal SB, Hale TL, Kapfer C, Cogan JP, Snoy PJ, Chung R, Wingfield ME, Elisberg BL, Baron LS.

Infect Immun. 1984 Nov;46(2):465-9.

25.

Unusual lipopolysaccharide antigens of a Salmonella typhi oral vaccine strain expressing the Shigella sonnei form I antigen.

Seid RC Jr, Kopecko DJ, Sadoff JC, Schneider H, Baron LS, Formal SB.

J Biol Chem. 1984 Jul 25;259(14):9028-34.

26.

Genetic studies of hybrids between coliphage phi 80 and Salmonella phage P22.

Yamamoto N, Gemski P, Baron LS.

J Gen Virol. 1983 Jan;64 (Pt 1):199-205.

PMID:
6822815
27.

Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.

Johnson EM, Diena BB, Lior H, Ryan A, Krol P, Baron LS.

Infect Immun. 1982 Oct;38(1):201-5.

28.

Intestinal immunoglobulin A responses in rabbits to a Salmonella typhi strain harboring a Shigella sonnei plasmid.

Keren DF, Collins HH, Baron LS, Kopecko DJ, Formal SB.

Infect Immun. 1982 Jul;37(1):387-9.

29.

Evaluation of two Salmonella typhi strains with reduced virulence for use in teaching and proficiency testing.

Hickman FW, Rhoden DL, Esaias AO, Baron LS, Brenner DJ, Farmer JJ 3rd.

J Clin Microbiol. 1982 Jun;15(6):1085-91.

30.

Genetic and molecular studies of the regulation of atypical citrate utilization and variable Vi antigen expression in enteric bacteria.

Baron LS, Kopecko DJ, McCowen SM, Snellings NJ, Johnson EM, Reid WC, Life CA.

Basic Life Sci. 1982;19:175-94.

PMID:
7039598
31.
32.

Evidence that ribosomal protein S10 participates in control of transcription termination.

Friedman DI, Schauer AT, Baumann MR, Baron LS, Adhya SL.

Proc Natl Acad Sci U S A. 1981 Feb;78(2):1115-8.

33.

Genetic regulation of variable Vi antigen expression in a strain of Citrobacter freundii.

Snellings NJ, Johnson EM, Kopecko DJ, Collins HH, Baron LS.

J Bacteriol. 1981 Feb;145(2):1010-7.

34.

L factor that is required for beta-galactosidase synthesis is the nusA gene product involved in transcription termination.

Greenblatt J, Li J, Adhya S, Friedman DI, Baron LS, Redfield B, Kung HF, Weissbach H.

Proc Natl Acad Sci U S A. 1980 Apr;77(4):1991-4.

35.

Mouse protective capabilities of Escherichia coli hybrids expressing Salmonella typhi antigens.

Diena BB, Lior H, Ryan A, Krol P, Johnson EM, Baron LS.

Infect Immun. 1979 Apr;24(1):90-3.

36.

lambdaimm P22dis: a hybrid of coliphage lambda with both immunity regions of Salmonella phage P22.

Yamamoto N, Wohlhieter JA, Gemski P, Baron LS.

Mol Gen Genet. 1978 Nov 9;166(3):233-43.

PMID:
368575
37.

Genetic studies of hybrids between coliphage lambda and salmonella phage P22: genetic analysis of the P22-lambda hybrid class.

Yamamoto N, Ushijima N, Gemski P, Baron LS.

Mol Gen Genet. 1977 Oct 20;155(2):117-21.

PMID:
337122
38.

Genetic basis of Vi antigen expression in Salmonella paratyphi C.

Snellings NJ, Johnson EM, Baron LS.

J Bacteriol. 1977 Jul;131(1):57-62.

39.

Effectiveness of parenteral and oral typhoid vaccination in mice challenged with a Salmonella typhi-Salmonella typhimurium hybrid.

Diena BB, Ryan A, Wallace R, Johnson EM, Baron LS, Ashton FE.

Infect Immun. 1977 Mar;15(3):997-8.

40.

Drug actions in bacteria.

Baron LS.

Science. 1976 Aug 27;193(4255):756-7. No abstract available.

PMID:
17747773
41.
42.

Plasmid-determined ability of a Salmonella tennessee strain to ferment lactose and sucrose.

Johnson EM, Wohlhieter JA, Placek BP, Sleet RB, Baron LS.

J Bacteriol. 1976 Jan;125(1):385-6.

43.
44.

Extensive segments of the Escherichia coli K12 chromosome in Proteus mirabilis diploids.

Wohlhieter JA, Gemski P Jr, Baron LS.

Mol Gen Genet. 1975 Aug 5;139(2):93-101.

PMID:
1101034
45.
46.
47.

Characterization of transmissible genetic elements from sucrose-fermenting Salmonella strains.

Wohlhieter JA, Lazere JR, Snellings NJ, Johnson EM, Synenki RM, Baron LS.

J Bacteriol. 1975 May;122(2):401-6.

48.

Intraperitoneal mouse virulence of Salmonella typhimurium hybrids expressing somatic antigen 9.

Johnson EM, Snellings NJ, Life CA, Baron LS.

Infect Immun. 1974 Sep;10(3):669-71.

49.

Role of typhoid antigens in protection and pathogenicity for mice.

Diena BB, Baron LS, Johnson EM, Wallace R, Ashton FE.

Infect Immun. 1974 Jun;9(6):1102-4.

50.

Genetic characterization of a bacterial locus involved in the activity of the N function of phage lambda.

Friedman DI, Baron LS.

Virology. 1974 Mar;58(1):141-8. No abstract available.

Supplemental Content

Loading ...
Support Center